Reply to Watkins and Rukazenkov (J Cell Mol Med 2010), re‐Letter of Response to manuscript entitled ‘Clinical outcomes in NSCLC patients with EGFR mutations: pooled analysis’ (Paz‐Ares et al., J Cell Mol Med. 2010; 14(1–2): 51–69)
Gespeichert in:
| Veröffentlicht in: | Journal of cellular and molecular medicine 2011-05, Vol.15 (5), p.1225-1225 |
|---|---|
| Hauptverfasser: | , , |
| Format: | Artikel |
| Sprache: | eng |
| Schlagworte: | |
| Online-Zugang: | Volltext bestellen |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
| container_end_page | 1225 |
|---|---|
| container_issue | 5 |
| container_start_page | 1225 |
| container_title | Journal of cellular and molecular medicine |
| container_volume | 15 |
| creator | Paz‐Ares, Luis Moecks, Joachim Klughammer, Barbara |
| description | |
| doi_str_mv | 10.1111/j.1582-4934.2011.01295.x |
| format | Article |
| fullrecord | <record><control><sourceid>proquest_24P</sourceid><recordid>TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_3822634</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>869000432</sourcerecordid><originalsourceid>FETCH-LOGICAL-c5025-3ff4e6c8a290533f7e85682485014c52c548f1c1417aa2982bffe5ea2c2072d63</originalsourceid><addsrcrecordid>eNqNUt1u0zAUjhCIjcEroCNxQSutwT9x6mwS0hRtg6kFVEBcWp7rMLdpHGJnW3fVR0DiBl6vj8AT4GxlMK6wdOQjn-9853zWF0WAUYzDeTGLMeNkkGQ0iQnCOEaYZCy-vBdt3xbub3LMKd-KHjk3Q4immGYPoy2CaRqCbEc_J7oul-AtfJJ-bioHsprCpJ3LK13N7Tn0TiDXZQljG0JPIYxD_V1o9Hr1daS91w3YAiba1bZyuiNayKp1qjG1B11548vQtV59z0tTGSVLsK1XdqEdmArevM9HOdTSmwB1cGH8GRweH01g0frwGCj3oLa2o5CVLJfOuPXqB_Teyasw_6AJLNqDLONduLtnfL3oPuCkh9erb6S_B6xL0qz_OHpQyNLpJ5t7J_p4dPghfzUYvT1-nR-MBoohwga0KBKdKi5JhhilxVBzlnKScIZwohhRLOEFVjjBQxkwnJwWhWZaEkXQkExTuhO9vOGt29OFnqqgsJGlqBuzkM1SWGnE3UplzsRney4oJySlSSB4viFo7JdWOy8WxqkgUlbatk7wNEMIJZQE5LN_kDPbNuHDnKBoyDI2zBAPKH6DUo11rtHF7S4Yic5XYiY6y4jOPqLzlbj2lbgMrU__1nLb-NtIf8RemFIv_5tYnOTjcZfSX45O3tQ</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>3075957908</pqid></control><display><type>article</type><title>Reply to Watkins and Rukazenkov (J Cell Mol Med 2010), re‐Letter of Response to manuscript entitled ‘Clinical outcomes in NSCLC patients with EGFR mutations: pooled analysis’ (Paz‐Ares et al., J Cell Mol Med. 2010; 14(1–2): 51–69)</title><source>Wiley Online Library Open Access</source><creator>Paz‐Ares, Luis ; Moecks, Joachim ; Klughammer, Barbara</creator><creatorcontrib>Paz‐Ares, Luis ; Moecks, Joachim ; Klughammer, Barbara</creatorcontrib><identifier>ISSN: 1582-1838</identifier><identifier>EISSN: 1582-4934</identifier><identifier>DOI: 10.1111/j.1582-4934.2011.01295.x</identifier><identifier>PMID: 21362132</identifier><language>eng</language><publisher>Oxford, UK: Blackwell Publishing Ltd</publisher><subject>Carcinoma, Non-Small-Cell Lung - drug therapy ; Carcinoma, Non-Small-Cell Lung - genetics ; Chemotherapy ; Humans ; Letter to the Editor ; Lung Neoplasms - drug therapy ; Lung Neoplasms - genetics ; Mutation - genetics ; Patients ; Protein Kinase Inhibitors - therapeutic use ; Receptor, Epidermal Growth Factor - genetics</subject><ispartof>Journal of cellular and molecular medicine, 2011-05, Vol.15 (5), p.1225-1225</ispartof><rights>2011 F. Hoffmann ‐ La Roche Ltd. Journal of Cellular and Molecular Medicine © 2011 Foundation for Cellular and Molecular Medicine/Blackwell Publishing Ltd</rights><rights>2011. This work is published under https://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.</rights><rights>2011 F. Hoffmann - La Roche Ltd. Journal of Cellular and Molecular Medicine © 2011 Foundation for Cellular and Molecular Medicine/Blackwell Publishing Ltd 2011</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c5025-3ff4e6c8a290533f7e85682485014c52c548f1c1417aa2982bffe5ea2c2072d63</citedby></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC3822634/pdf/$$EPDF$$P50$$Gpubmedcentral$$Hfree_for_read</linktopdf><linktohtml>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC3822634/$$EHTML$$P50$$Gpubmedcentral$$Hfree_for_read</linktohtml><link.rule.ids>230,314,723,776,780,881,1411,11541,27901,27902,45550,45551,46027,46451,53766,53768</link.rule.ids><linktorsrc>$$Uhttps://onlinelibrary.wiley.com/doi/abs/10.1111%2Fj.1582-4934.2011.01295.x$$EView_record_in_Wiley-Blackwell$$FView_record_in_$$GWiley-Blackwell</linktorsrc><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/21362132$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Paz‐Ares, Luis</creatorcontrib><creatorcontrib>Moecks, Joachim</creatorcontrib><creatorcontrib>Klughammer, Barbara</creatorcontrib><title>Reply to Watkins and Rukazenkov (J Cell Mol Med 2010), re‐Letter of Response to manuscript entitled ‘Clinical outcomes in NSCLC patients with EGFR mutations: pooled analysis’ (Paz‐Ares et al., J Cell Mol Med. 2010; 14(1–2): 51–69)</title><title>Journal of cellular and molecular medicine</title><addtitle>J Cell Mol Med</addtitle><subject>Carcinoma, Non-Small-Cell Lung - drug therapy</subject><subject>Carcinoma, Non-Small-Cell Lung - genetics</subject><subject>Chemotherapy</subject><subject>Humans</subject><subject>Letter to the Editor</subject><subject>Lung Neoplasms - drug therapy</subject><subject>Lung Neoplasms - genetics</subject><subject>Mutation - genetics</subject><subject>Patients</subject><subject>Protein Kinase Inhibitors - therapeutic use</subject><subject>Receptor, Epidermal Growth Factor - genetics</subject><issn>1582-1838</issn><issn>1582-4934</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2011</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><sourceid>BENPR</sourceid><recordid>eNqNUt1u0zAUjhCIjcEroCNxQSutwT9x6mwS0hRtg6kFVEBcWp7rMLdpHGJnW3fVR0DiBl6vj8AT4GxlMK6wdOQjn-9853zWF0WAUYzDeTGLMeNkkGQ0iQnCOEaYZCy-vBdt3xbub3LMKd-KHjk3Q4immGYPoy2CaRqCbEc_J7oul-AtfJJ-bioHsprCpJ3LK13N7Tn0TiDXZQljG0JPIYxD_V1o9Hr1daS91w3YAiba1bZyuiNayKp1qjG1B11548vQtV59z0tTGSVLsK1XdqEdmArevM9HOdTSmwB1cGH8GRweH01g0frwGCj3oLa2o5CVLJfOuPXqB_Teyasw_6AJLNqDLONduLtnfL3oPuCkh9erb6S_B6xL0qz_OHpQyNLpJ5t7J_p4dPghfzUYvT1-nR-MBoohwga0KBKdKi5JhhilxVBzlnKScIZwohhRLOEFVjjBQxkwnJwWhWZaEkXQkExTuhO9vOGt29OFnqqgsJGlqBuzkM1SWGnE3UplzsRney4oJySlSSB4viFo7JdWOy8WxqkgUlbatk7wNEMIJZQE5LN_kDPbNuHDnKBoyDI2zBAPKH6DUo11rtHF7S4Yic5XYiY6y4jOPqLzlbj2lbgMrU__1nLb-NtIf8RemFIv_5tYnOTjcZfSX45O3tQ</recordid><startdate>201105</startdate><enddate>201105</enddate><creator>Paz‐Ares, Luis</creator><creator>Moecks, Joachim</creator><creator>Klughammer, Barbara</creator><general>Blackwell Publishing Ltd</general><general>John Wiley & Sons, Inc</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>3V.</scope><scope>7QP</scope><scope>7TK</scope><scope>7X7</scope><scope>7XB</scope><scope>88E</scope><scope>88I</scope><scope>8AO</scope><scope>8FD</scope><scope>8FE</scope><scope>8FH</scope><scope>8FI</scope><scope>8FJ</scope><scope>8FK</scope><scope>ABUWG</scope><scope>AFKRA</scope><scope>AZQEC</scope><scope>BBNVY</scope><scope>BENPR</scope><scope>BHPHI</scope><scope>CCPQU</scope><scope>DWQXO</scope><scope>FR3</scope><scope>FYUFA</scope><scope>GHDGH</scope><scope>GNUQQ</scope><scope>HCIFZ</scope><scope>K9.</scope><scope>LK8</scope><scope>M0S</scope><scope>M1P</scope><scope>M2P</scope><scope>M7P</scope><scope>P64</scope><scope>PIMPY</scope><scope>PQEST</scope><scope>PQQKQ</scope><scope>PQUKI</scope><scope>PRINS</scope><scope>Q9U</scope><scope>RC3</scope><scope>7X8</scope><scope>5PM</scope></search><sort><creationdate>201105</creationdate><title>Reply to Watkins and Rukazenkov (J Cell Mol Med 2010), re‐Letter of Response to manuscript entitled ‘Clinical outcomes in NSCLC patients with EGFR mutations: pooled analysis’ (Paz‐Ares et al., J Cell Mol Med. 2010; 14(1–2): 51–69)</title><author>Paz‐Ares, Luis ; Moecks, Joachim ; Klughammer, Barbara</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c5025-3ff4e6c8a290533f7e85682485014c52c548f1c1417aa2982bffe5ea2c2072d63</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2011</creationdate><topic>Carcinoma, Non-Small-Cell Lung - drug therapy</topic><topic>Carcinoma, Non-Small-Cell Lung - genetics</topic><topic>Chemotherapy</topic><topic>Humans</topic><topic>Letter to the Editor</topic><topic>Lung Neoplasms - drug therapy</topic><topic>Lung Neoplasms - genetics</topic><topic>Mutation - genetics</topic><topic>Patients</topic><topic>Protein Kinase Inhibitors - therapeutic use</topic><topic>Receptor, Epidermal Growth Factor - genetics</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Paz‐Ares, Luis</creatorcontrib><creatorcontrib>Moecks, Joachim</creatorcontrib><creatorcontrib>Klughammer, Barbara</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>ProQuest Central (Corporate)</collection><collection>Calcium & Calcified Tissue Abstracts</collection><collection>Neurosciences Abstracts</collection><collection>Health & Medical Collection</collection><collection>ProQuest Central (purchase pre-March 2016)</collection><collection>Medical Database (Alumni Edition)</collection><collection>Science Database (Alumni Edition)</collection><collection>ProQuest Pharma Collection</collection><collection>Technology Research Database</collection><collection>ProQuest SciTech Collection</collection><collection>ProQuest Natural Science Collection</collection><collection>Hospital Premium Collection</collection><collection>Hospital Premium Collection (Alumni Edition)</collection><collection>ProQuest Central (Alumni) (purchase pre-March 2016)</collection><collection>ProQuest Central (Alumni Edition)</collection><collection>ProQuest Central UK/Ireland</collection><collection>ProQuest Central Essentials</collection><collection>Biological Science Collection</collection><collection>ProQuest Central</collection><collection>Natural Science Collection</collection><collection>ProQuest One Community College</collection><collection>ProQuest Central Korea</collection><collection>Engineering Research Database</collection><collection>Health Research Premium Collection</collection><collection>Health Research Premium Collection (Alumni)</collection><collection>ProQuest Central Student</collection><collection>SciTech Premium Collection</collection><collection>ProQuest Health & Medical Complete (Alumni)</collection><collection>ProQuest Biological Science Collection</collection><collection>Health & Medical Collection (Alumni Edition)</collection><collection>Medical Database</collection><collection>Science Database</collection><collection>Biological Science Database</collection><collection>Biotechnology and BioEngineering Abstracts</collection><collection>Publicly Available Content Database</collection><collection>ProQuest One Academic Eastern Edition (DO NOT USE)</collection><collection>ProQuest One Academic</collection><collection>ProQuest One Academic UKI Edition</collection><collection>ProQuest Central China</collection><collection>ProQuest Central Basic</collection><collection>Genetics Abstracts</collection><collection>MEDLINE - Academic</collection><collection>PubMed Central (Full Participant titles)</collection><jtitle>Journal of cellular and molecular medicine</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext_linktorsrc</fulltext></delivery><addata><au>Paz‐Ares, Luis</au><au>Moecks, Joachim</au><au>Klughammer, Barbara</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Reply to Watkins and Rukazenkov (J Cell Mol Med 2010), re‐Letter of Response to manuscript entitled ‘Clinical outcomes in NSCLC patients with EGFR mutations: pooled analysis’ (Paz‐Ares et al., J Cell Mol Med. 2010; 14(1–2): 51–69)</atitle><jtitle>Journal of cellular and molecular medicine</jtitle><addtitle>J Cell Mol Med</addtitle><date>2011-05</date><risdate>2011</risdate><volume>15</volume><issue>5</issue><spage>1225</spage><epage>1225</epage><pages>1225-1225</pages><issn>1582-1838</issn><eissn>1582-4934</eissn><cop>Oxford, UK</cop><pub>Blackwell Publishing Ltd</pub><pmid>21362132</pmid><doi>10.1111/j.1582-4934.2011.01295.x</doi><tpages>1</tpages><oa>free_for_read</oa></addata></record> |
| fulltext | fulltext_linktorsrc |
| identifier | ISSN: 1582-1838 |
| ispartof | Journal of cellular and molecular medicine, 2011-05, Vol.15 (5), p.1225-1225 |
| issn | 1582-1838 1582-4934 |
| language | eng |
| recordid | cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_3822634 |
| source | Wiley Online Library Open Access |
| subjects | Carcinoma, Non-Small-Cell Lung - drug therapy Carcinoma, Non-Small-Cell Lung - genetics Chemotherapy Humans Letter to the Editor Lung Neoplasms - drug therapy Lung Neoplasms - genetics Mutation - genetics Patients Protein Kinase Inhibitors - therapeutic use Receptor, Epidermal Growth Factor - genetics |
| title | Reply to Watkins and Rukazenkov (J Cell Mol Med 2010), re‐Letter of Response to manuscript entitled ‘Clinical outcomes in NSCLC patients with EGFR mutations: pooled analysis’ (Paz‐Ares et al., J Cell Mol Med. 2010; 14(1–2): 51–69) |
| url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-02-08T20%3A12%3A14IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_24P&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Reply%20to%20Watkins%20and%20Rukazenkov%20(J%20Cell%20Mol%20Med%202010),%20re%E2%80%90Letter%20of%20Response%20to%20manuscript%20entitled%20%E2%80%98Clinical%20outcomes%20in%20NSCLC%20patients%20with%20EGFR%20mutations:%20pooled%20analysis%E2%80%99%20(Paz%E2%80%90Ares%20et%20al.,%20J%20Cell%20Mol%20Med.%202010;%2014(1%E2%80%932):%2051%E2%80%9369)&rft.jtitle=Journal%20of%20cellular%20and%20molecular%20medicine&rft.au=Paz%E2%80%90Ares,%20Luis&rft.date=2011-05&rft.volume=15&rft.issue=5&rft.spage=1225&rft.epage=1225&rft.pages=1225-1225&rft.issn=1582-1838&rft.eissn=1582-4934&rft_id=info:doi/10.1111/j.1582-4934.2011.01295.x&rft_dat=%3Cproquest_24P%3E869000432%3C/proquest_24P%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=3075957908&rft_id=info:pmid/21362132&rfr_iscdi=true |